Paccaud, Lausanne (Mdecine sociale et prventive)
Following guidance from regulatory bodies (FDA and EMA), several CVOTs have been conducted to examine the safety and tolerability of GLP-1 RAs, which include ELIXA (lixisenatide) [53], LEADER (liraglutide) [54], SUSTAIN (injectable semaglutide) [55] EXSCEL (exenatide ER) [56], HARMONY (albiglutide) [57], REWIND (dulaglutide) [58], and PIONEER 6 (oral semaglutide) [59]
Molto interessante anche la presenza dello squalano vegetale, ingrediente particolarmente apprezzato nelle skincare dedicate a pelle secca, sensibile o segnata da disidratazione
Hemolytic anemia, severe vas occlusion, and persistent organ destruction are all symptoms of this multisystem, autosomal recessive illness [2]
N-Acetylcysteine and glutathione interplay in human cells